1. Home
  2. Labeler Index
  3. Astrazeneca Ab
  4. 17228-4611
  5. NDC Package Code: 17228-4611-6 Durvalumab

NDC Package 17228-4611-6 Durvalumab

Injection, Solution - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
17228-4611-6
Package Description:
330 VIAL in 1 TRAY / 10 mL in 1 VIAL
Product Code:
17228-4611
Non-Proprietary Name:
Durvalumab
Substance Name:
Durvalumab
Usage Information:
Durvalumab is used to treat a certain type of bladder and urinary tract cancer. It is also used to treat lung cancer. It works by helping your immune system fight the cancer. This medication belongs to a class of drugs known as monoclonal antibodies.
11-Digit NDC Billing Format:
17228461106
Product Type:
Drug For Further Processing
Labeler Name:
Astrazeneca Ab
Dosage Form:
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Active Ingredient(s):
  • DURVALUMAB 500 mg/10mL
    • Sample Package:
    N/A
    Marketing Category:
    DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
    Start Marketing Date:
    01-01-2020
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Unfinished Product:
    Yes
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    17228-4611-5330 VIAL in 1 TRAY / 10 mL in 1 VIAL

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 17228-4611-6?

    The NDC Packaged Code 17228-4611-6 is assigned to an UNFINISHED drug package of 330 vial in 1 tray / 10 ml in 1 vial of Durvalumab, drug for further processing labeled by Astrazeneca Ab. The product's dosage form is injection, solution and is administered via form.

    Is NDC 17228-4611 included in the NDC Directory?

    Yes, Durvalumab is an UNFINISHED PRODUCT with code 17228-4611 that is active and included in the NDC Directory. The product was first marketed by Astrazeneca Ab on January 01, 2020 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 17228-4611-6?

    The 11-digit format is 17228461106. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-117228-4611-65-4-217228-4611-06